NBE-Therapeutics has been awarded a CHF 1.0 mio grant of the Swiss Commission for Technology and Innovation (CTI) for an ETH collaboration

NBE-Therapeutics has received a CHF 1.0 mio R&D grant for a two-year R&D collaboration with the group of Prof. Sai Reddy at the Department of Biosystems Science and Engineering (D-BSSE) of ETH Zürich. This R&D collaboration is focused at combining the expert know-how of Prof. Reddy's group in applying next-generation and high throughput DNA sequencing for the identification of specific antibody sequences, with the expertise of NBE-Therapeutics in antibody discovery and engineering. The collaboration is geared toward the discovery of panels of therapeutic antibody candidates against oncology targets that are intended to be developed into potent antibody drug conjugates (ADCs).